今日10x Genomics (TXG)股价上涨原因解析 - Finviz
Why 10x Genomics (TXG) Stock Is Trading Up Today - Finviz
生物技术与制药领域的最新动态
Why 10x Genomics (TXG) Stock Is Trading Up Today - Finviz
10x Genomics (Nasdaq: TXG) to join Wolfe Research Healthcare Conference at 11:20 a.m. ET - Stock Titan
10x Genomics (TXG) Soars to New Record High on Lower Net Loss, Revenue Beat - Yahoo Finance
Why 10x Genomics (TXG) Stock Is Trading Up Today - Yahoo Finance
10x Genomics to Participate in the Wolfe Research Healthcare Conference 2025 - PR Newswire
10x Genomics stock hits 52-week high at 17.26 USD - Investing.com
10x Genomics, Inc. (NASDAQ:TXG) Q3 2025 Earnings Call Transcript - Insider Monkey
Does 10x Genomics' (TXG) Q4 Outlook Signal Shifting Demand or Product Innovation Taking Hold? - Yahoo Finance
Barclays Maintains 10x Genomics (TXG) Overweight Recommendation - Nasdaq
JP Morgan Maintains 10x Genomics (TXG) Neutral Recommendation - Nasdaq
Why 10x Genomics (TXG) Stock Is Trading Up Today - Yahoo Finance
10X Genomics Tops Q3 Estimates And Cuts Losses - Finimize
10x Genomics’s (NASDAQ:TXG) Q3: Strong Sales, Stock Jumps 13.1% - Markets Financial Content
10x Genomics Reports Third Quarter 2025 Financial Results - Barchart.com
10x Genomics Reports Third Quarter 2025 Financial Results - Eastern Progress
10x Genomics (TXG) Reports Q3 Loss, Beats Revenue Estimates - Nasdaq
10X Genomics earnings beat by $0.07, revenue topped estimates - Investing.com
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics - Nasdaq
10x Genomics (NASDAQ: TXG) guides fourth‑quarter revenue to $154–$158M after results - Stock Titan
Compared to Estimates, 10x Genomics (TXG) Q3 Earnings: A Look at Key Metrics - Yahoo Finance